Oxford Science Enterprises plc
CIK: 0001856079
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Oxford Science Enterprises plc
Oxford Science Enterprises plc (SEC CIK 0001856079) files insider reports with the SEC as Barinthus Biotherapeutics plc. (BRNS) and PepGen Inc. (PEPG).
Signal8 holds 2 ownership filings by Oxford Science Enterprises plc, all Form 4s, filed between Oct 1, 2025 and Sep 11, 2026. Those filings report 2 transactions, from Sep 30, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Oxford Science Enterprises plc's filings is in OXFORD.
Recent filings by Oxford Science Enterprises plc
Other insiders filing for Barinthus Biotherapeutics plc. (BRNS)
- Wright Robin, Director
- Scheeren Joseph, Director
- Phillips Anne M., Director
- Morgon Pierre A., Director
- Hooftman Leon, Chief Medical Officer
- Hammacher Alex, Director